MAIA Biotechnology Inc (MAIA)
3.00
+0.07
(+2.39%)
USD |
NYAM |
May 01, 11:14
MAIA Biotechnology Free Cash Flow: -13.07M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -13.07M |
| September 30, 2023 | -12.03M |
| June 30, 2023 | -13.19M |
| March 31, 2023 | -12.65M |
| December 31, 2022 | -12.10M |
| Date | Value |
|---|---|
| September 30, 2022 | -10.75M |
| June 30, 2022 | -7.746M |
| March 31, 2022 | -6.677M |
| December 31, 2021 | -4.123M |
Free Cash Flow Range, Past 5 Years
-13.19M
Minimum
Jun 2023
-4.123M
Maximum
Dec 2021
-10.26M
Average
-12.03M
Median
Sep 2023
Free Cash Flow Benchmarks
| Cyclacel Pharmaceuticals Inc | -16.12M |
| Avid Bioservices Inc | -38.50M |
| Oragenics Inc | -7.291M |
| NeuBase Therapeutics Inc | -14.85M |
| Viking Therapeutics Inc | -54.87M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.992M |
| Cash from Financing (Quarterly) | 5.025M |
| Free Cash Flow Per Share (Quarterly) | -0.2579 |
| Free Cash Flow Yield | -32.87% |